Rapid Response Revival is dedicated to improving the design, portability, cost and ease-of-use of automated external defibrillators (AEDs). AEDs save lives. Their purpose is to make early defibrillation available to people experiencing out-of-hospital cardiac arrest (OHCA). Globally, more than six million people die every year from sudden cardiac arrest, with a survival rate of less than 1 per cent.1 Most of these deaths – more than 80 per cent – occur in homes.2 Rapid Response Revival is pioneering a solution to barriers to AED use and home ownership, including portability, ease of use, and cost. That solution is CellAED®.
Rapid Response Revival is currently undergoing rigorous assessments required of medical device regulators around the world.
CellAED® achieved CE Certification in May 2021, which applies to Member States of the European Economic Area and is also approved for sale in the United Kingdom, Australia, New Zealand and Taiwan.
Rapid Response Revival is actively seeking regulatory approval for CellAED® in other jurisdictions around the world.
1 Global public health problem of sudden cardiac arrest (Rahul Mehra) https://pubmed.ncbi.nlm.nih.gov/17993308/ 2 In the US, 69.8% OHCA occurs in homes, and another 11.5% in nursing homes (source: American Safety & Health Institute)
If you haven’t found what you’re looking for, we invite you to contact us by selecting the relevant enquiry form from the categories below.